Dr. Reddys Labs (RDY), Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
Go back to Dr. Reddys Labs (RDY), Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug| DR. REDDY'S LAB LTD ADR (NYSE: RDY) | Delayed: 12.18 +0.02 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.16 | 52 Week High | $54.73 | |||
| Open | $12.33 | 52 Week Low | $40.68 | |||
| Day High | $12.33 | P/E | N/A | |||
| Day Low | $12.12 | EPS | $0.00 | |||
| Volume | 1,674,279 | |||||

